Product Information
MINOCYCLINE ER 105 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $1.7342 per EA under NDC 67877043830. Its NADAC has been published 100 times since Aug 21, 2024.
FDA first approved this application on Sep 28, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Minocycline Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
105 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877043830
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
7/23/2025
Active Ingredients
MINOCYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204453FDA Approved
9/28/2016
TE Code
AB
On Market Since
9/30/2016
Pharmacological Classes
Price Statistics
The NADAC for MINOCYCLINE ER 105 MG TABLET has been published 100 times since Aug 21, 2024, and over the history we have for it it has declined 47.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7342 per EA |
|---|---|
| All-time high | $3.3074 (Oct 16, 2024) |
| All-time low | $1.7342 (Jun 18, 2025) |
| 52-week high | $1.7342 |
| 52-week low | $1.7342 |
| Median price | $1.7342 |
| Average price | $2.0994 |
| Largest weekly change | -12.6% (Apr 23, 2025) |
| Weeks tracked | 100 |
| Tracking since | Aug 21, 2024 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
-47.6%
Last surveyed Jul 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MINOCYCLINE ER 105 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MINOCYCLINE ER 105 MG TABLET, manufactured by Ascend Laboratories, LLC, is $1.7342 per EA (NDC 67877043830), effective Jul 15, 2026.
How has the price of MINOCYCLINE ER 105 MG TABLET changed over time?
Over the history we have for it, the NADAC for MINOCYCLINE ER 105 MG TABLET has declined 47.6%. It has been tracked across 100 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for MINOCYCLINE ER 105 MG TABLET?
Since Aug 21, 2024, the NADAC for MINOCYCLINE ER 105 MG TABLET has ranged from a low of $1.7342 (Jun 18, 2025) to a high of $3.3074 (Oct 16, 2024), with a median of $1.7342 per EA.
Are there cheaper alternatives to MINOCYCLINE ER 105 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MINOCYCLINE ER 105 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MINOCYCLINE ER 105 MG TABLET?
MINOCYCLINE ER 105 MG TABLET (NDC 67877043830) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.